PET/MRI Artificial Intelligence Reconstruction Algorithm AIR Recon DL Image Quality Evaluation and Clinical Study

N/AActive Not RecruitingNCT06856096

Xijing Hospital65 enrolled

Overview

PET/MRI artificial intelligence reconstruction algorithm AIR Recon DL image quality evaluation and clinical study

This is a diagnostic pilot study in which 50 patients with disorders of consciousness, Parkinson's syndrome and 15 prostate cancer patients were recruited to undergo PET/MRI imaging to evaluate the impact of AIR Recon DL on scanning and imaging time in different diseases and imaging sites, to determine its efficiency in clinical applications and to analyse its potential advantages in the diagnosis of specific diseases.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Parkinson's Syndrome

Interventions

PET/MRIDIAGNOSTIC_TEST

PET/MR imaging using an integrated TOF PET/MR scanner (Signa, GE Healthcare, WI, USA)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. Adults between the ages of 18 and 75 who are autonomous; 2. persons with good compliance; 3. those who are mentally alert and able to move around on their own; 4. Those who agree to participate in this clinical trial and sign the informed consent form. Exclusion Criteria: * 1\. Persons who do not have full capacity for civil behaviour; 2. Women during pregnancy and breastfeeding; 3. other implants, prostheses, foreign bodies and patches with electronic implants such as pacemakers, insulin pumps and cochlear implants that are not suitable for MRI; 4. patients with claustrophobia; 5. those who, in the opinion of the investigator, are not suitable for participation in this clinical trial.

Locations (1)

Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China, Xi'an, Shaanxi Province

Xi'an, Shaanxi, China

Outcomes

Primary Outcomes

Signal to Noise Ratio

An important parameter for measuring image quality, indicating the ratio of signal to noise power

Time frame: 1 day from injection of the tracer

Contrast to Noise Ratio

Describes the relative difference in signal strength between the two tissues, the greater the difference the better the image comparison

Time frame: 1 day from injection of the tracer

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.